Efficacy and Safety of Ticagrelor and Aspirin in Patients With Moderate Ischemic Stroke: An Exploratory Analysis of the THALES Randomized Clinical Trial

IMPORTANCE: Prior trials of dual antiplatelet therapy excluded patients with moderate ischemic stroke. These patients were included in the Acute Stroke or Transient Ischaemic Attack Treated With Ticagrelor and ASA for Prevention of Stroke and Death (THALES) trial, but results have not been reported...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yongjun, Pan, Yuesong, Li, Hao, Amarenco, Pierre, Denison, Hans, Evans, Scott R., Himmelmann, Anders, James, Stefan, Birve, Filip, Ladenvall, Per, Molina, Carlos A., Johnston, S. Claiborne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430457/
https://www.ncbi.nlm.nih.gov/pubmed/34244703
http://dx.doi.org/10.1001/jamaneurol.2021.2440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430457/
https://www.ncbi.nlm.nih.gov/pubmed/34244703
http://dx.doi.org/10.1001/jamaneurol.2021.2440

Ejemplares similares